Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy

Xiaoxiao Liu1,2, Baolei Li1,3, Shuyun Wang1

  • 1Department of Cardiac Surgery (X.L., B.L., S.W., D.X., M.-S.S.), Michigan Medicine, Ann Arbor.

Circulation Research
|February 28, 2024
PubMed

Insights

The secreted axon guidance molecule SLIT3, produced by cardiac stromal cells, promotes cardiomyocyte hypertrophy and adverse remodeling in response to pressure overload stress via the SLIT3-ROBO1 axis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Developmental Biology

Background:

  • The secreted axon guidance molecule SLIT3 is expressed in the postnatal heart.
  • Its role in postnatal cardiovascular function, particularly under stress, is largely unknown.
  • This study investigates SLIT3's sources and function in the postnatal heart.

Purpose of the Study:

  • Determine postnatal myocardial sources of SLIT3.
  • Evaluate SLIT3's role in the cardiac response to pressure overload.
  • Elucidate the SLIT3-ROBO1 signaling pathway in cardiac remodeling.

Main Methods:

  • In vitro studies on cardiomyocytes and patient myocardial tissue.
  • In vivo studies using SLIT3 and ROBO1 mutant mice subjected to transverse aortic constriction.
  • Genetic manipulation including cell-specific knockouts of SLIT3 and ROBO1.

Main Results:

  • SLIT3 transcription increased in human hearts with pressure overload.
  • SLIT3 is secreted by cardiac fibroblasts and vascular mural cells, stimulating cardiomyocyte hypertrophy.
  • SLIT3-ROBO1 signaling mediates hypertrophy and adverse cardiac remodeling in response to pressure overload.
  • Genetic deletion of SLIT3 or ROBO1 attenuated hypertrophy and preserved cardiac function.

Conclusions:

  • SLIT3 is a novel regulator of postnatal cardiac response to pressure overload.
  • The SLIT3-ROBO1 axis plays a critical role in cardiac hypertrophy and remodeling.
  • Targeting this pathway may offer therapeutic strategies for heart disease.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...